RIMEGEPANT SULFATE

RIMEGEPANT SULFATE was reported 13010 times

RIMEGEPANT SULFATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 POSTNATAL GROWTH RESTRICTION 49 0.3740
1 ACQUIRED PLAGIOCEPHALY 7 0.1892
2 ABDOMINAL MIGRAINE 5 0.0735
3 REACTION TO FOOD ADDITIVE 7 0.0519
4 FAILED INDUCTION OF LABOUR 9 0.0464
5 THERAPEUTIC PRODUCT EFFECT VARIABLE 179 0.0461
6 MEDICATION OVERUSE HEADACHE 37 0.0432
7 BARBITURATES POSITIVE 3 0.0375
8 THERAPEUTIC PRODUCT EFFECT DELAYED 133 0.0291
9 SUBCHORIONIC HAEMORRHAGE 4 0.0272
10 DEAFNESS PERMANENT 5 0.0255
11 MANIC SYMPTOM 4 0.0238
12 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 8 0.0187
13 VESTIBULAR MIGRAINE 4 0.0166
14 GESTATIONAL HYPERTENSION 21 0.0163
15 GROSS MOTOR DELAY 4 0.0141
16 PRODUCT AFTER TASTE 13 0.0136
17 MIGRAINE WITHOUT AURA 4 0.0133
18 OPHTHALMIC MIGRAINE 9 0.0129
19 MORNING SICKNESS 7 0.0128
20 PRODUCT DOSAGE FORM ISSUE 6 0.0124
21 HEMIPLEGIC MIGRAINE 4 0.0118
22 ANION GAP DECREASED 4 0.0115
23 ALLERGY TO PLANTS 5 0.0109
24 AURA 20 0.0107
25 FACTOR V LEIDEN MUTATION 4 0.0101
26 ARTERY DISSECTION 4 0.0097
27 MIGRAINE 885 0.0093
28 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 649 0.0091
29 REACTION TO EXCIPIENT 21 0.0091
30 OCCIPITAL NEURALGIA 5 0.0088
31 THERAPEUTIC PRODUCT EFFECT PROLONGED 4 0.0088
32 PRODUCT ADMINISTRATION INTERRUPTED 69 0.0088
33 MOTOR DEVELOPMENTAL DELAY 5 0.0087
34 MAST CELL ACTIVATION SYNDROME 12 0.0085
35 GASTROINTESTINAL MICROORGANISM OVERGROWTH 3 0.0085
36 THERAPEUTIC RESPONSE DELAYED 21 0.0075
37 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 9 0.0067
38 COMPLICATION OF PREGNANCY 5 0.0066
39 PLACENTA PRAEVIA 5 0.0064
40 APGAR SCORE LOW 8 0.0062
41 NASAL CRUSTING 4 0.0062
42 MIGRAINE WITH AURA 16 0.0059
43 POLYHYDRAMNIOS 6 0.0059
44 FEELING OF RELAXATION 4 0.0058
45 TONGUE PRURITUS 5 0.0058
46 DRUG EFFECT LESS THAN EXPECTED 85 0.0057
47 FACIAL DISCOMFORT 4 0.0056
48 CERVICAL RADICULOPATHY 4 0.0056
49 TENSION HEADACHE 24 0.0056
50 INFUSION SITE MASS 6 0.0055
51 THERAPEUTIC PRODUCT EFFECT DECREASED 243 0.0054
52 AMINO ACID LEVEL INCREASED 4 0.0054
53 LIVE BIRTH 45 0.0054
54 EUSTACHIAN TUBE DYSFUNCTION 3 0.0052
55 CLUSTER HEADACHE 7 0.0051
56 MAGNETIC RESONANCE IMAGING ABNORMAL 6 0.0050
57 ALLERGIC REACTION TO EXCIPIENT 10 0.0050
58 PRODUCT PACKAGING DIFFICULT TO OPEN 13 0.0050
59 DIAPHRAGMATIC HERNIA 3 0.0048
60 INFUSION SITE DISCOMFORT 5 0.0048
61 INFECTED BITE 4 0.0047
62 CRANIOFACIAL FRACTURE 4 0.0047
63 ALLERGIC SINUSITIS 4 0.0047
64 PRE-ECLAMPSIA 22 0.0046
65 INFUSION SITE DISCHARGE 8 0.0046
66 PREMATURE SEPARATION OF PLACENTA 7 0.0045
67 POSTPARTUM HAEMORRHAGE 6 0.0045
68 ELECTRIC SHOCK SENSATION 12 0.0043
69 WRIST SURGERY 4 0.0043
70 HANGOVER 15 0.0043
71 FOETAL HEART RATE DECELERATION ABNORMALITY 3 0.0042
72 OBSTRUCTIVE SLEEP APNOEA SYNDROME 6 0.0041
73 PHARYNGEAL SWELLING 40 0.0041
74 PRODUCT SOLUBILITY ABNORMAL 20 0.0040
75 INFUSION SITE IRRITATION 5 0.0039
76 VOMITING PROJECTILE 11 0.0038
77 INCORRECT DRUG ADMINISTRATION RATE 16 0.0038
78 INFUSION SITE BRUISING 8 0.0037
79 ALTERED VISUAL DEPTH PERCEPTION 3 0.0037
80 THERAPEUTIC RESPONSE SHORTENED 121 0.0036
81 INFUSION SITE RASH 5 0.0036
82 GIANT CELL ARTERITIS 3 0.0036
83 PERIPHERAL ARTERY THROMBOSIS 5 0.0036
84 IDIOPATHIC INTRACRANIAL HYPERTENSION 8 0.0036
85 TONGUE DISCOMFORT 15 0.0035
86 CORONARY ARTERY DISSECTION 3 0.0035
87 INFUSION SITE PRURITUS 11 0.0035
88 CERVICAL SPINAL STENOSIS 6 0.0035
89 NOROVIRUS INFECTION 5 0.0035
90 ENDOCRINE OPHTHALMOPATHY 3 0.0035
91 BRAIN FOG 54 0.0034
92 EYELID PAIN 7 0.0034
93 HYPOTHALAMO-PITUITARY DISORDER 5 0.0034
94 PRODUCT USE COMPLAINT 54 0.0034
95 SLEEP PARALYSIS 5 0.0034
96 COMPLEX REGIONAL PAIN SYNDROME 5 0.0034
97 BRONCHIAL HYPERREACTIVITY 4 0.0033
98 EMERGENCY CARE 10 0.0033
99 POST-ACUTE COVID-19 SYNDROME 4 0.0032
100 PARAESTHESIA ORAL 46 0.0032
101 INHIBITORY DRUG INTERACTION 5 0.0032
102 EAR PRURITUS 11 0.0031
103 DRUG INEFFECTIVE 4108 0.0031
104 MOTION SICKNESS 6 0.0031
105 HEAD DISCOMFORT 55 0.0031
106 PRODUCT TASTE ABNORMAL 42 0.0031
107 IMPAIRED GASTRIC EMPTYING 42 0.0031
108 MEDICAL PROCEDURE 5 0.0030
109 SINUS PAIN 7 0.0030
110 HAEMANGIOMA OF LIVER 3 0.0030
111 BUTTERFLY RASH 3 0.0030
112 GESTATIONAL DIABETES 14 0.0029
113 EXPOSURE DURING PREGNANCY 176 0.0028
114 TORTICOLLIS 6 0.0028
115 FEELING DRUNK 21 0.0028
116 OESOPHAGEAL SPASM 5 0.0027
117 ESSENTIAL TREMOR 3 0.0027
118 HYPERACUSIS 10 0.0027
119 INFUSION SITE REACTION 8 0.0027
120 GASTROINTESTINAL HYPOMOTILITY 6 0.0027
121 POOR QUALITY PRODUCT ADMINISTERED 28 0.0027
122 CORTISOL DECREASED 3 0.0026
123 RUBBER SENSITIVITY 4 0.0026
124 ADMINISTRATION SITE PAIN 3 0.0026
125 NECK SURGERY 6 0.0026
126 BLADDER OPERATION 3 0.0026
127 ALLODYNIA 3 0.0026
128 EXPOSURE VIA BREAST MILK 10 0.0025
129 PRODUCT PHYSICAL ISSUE 50 0.0025
130 ENURESIS 10 0.0025
131 CONCUSSION 19 0.0025
132 SUSPECTED OFF LABEL USE 11 0.0024
133 DEVICE INFUSION ISSUE 6 0.0024
134 ATTENTION DEFICIT HYPERACTIVITY DISORDER 10 0.0024
135 ABORTION MISSED 3 0.0024
136 PERFORMANCE STATUS DECREASED 11 0.0024
137 TACHYPHRENIA 8 0.0023
138 SKIN HYPOPIGMENTATION 4 0.0023
139 TERMINAL INSOMNIA 4 0.0023
140 HYPOAESTHESIA ORAL 34 0.0023
141 NASAL OEDEMA 4 0.0022
142 ANEURYSM 11 0.0022
143 ESSENTIAL HYPERTENSION 4 0.0022
144 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 118 0.0021
145 TUNNEL VISION 4 0.0021
146 INFUSION SITE HAEMORRHAGE 7 0.0021
147 NARCOLEPSY 4 0.0021
148 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 3 0.0021
149 MOUTH SWELLING 12 0.0021
150 NECK INJURY 6 0.0020
151 COCCYDYNIA 3 0.0020
152 CARTILAGE INJURY 5 0.0020
153 ACNE CYSTIC 6 0.0020
154 ILLNESS 205 0.0020
155 TRIGEMINAL NEURALGIA 8 0.0020
156 INSURANCE ISSUE 30 0.0020
157 EAR DISCOMFORT 20 0.0019
158 PRODUCT DISTRIBUTION ISSUE 18 0.0019
159 PRE-EXISTING CONDITION IMPROVED 12 0.0019
160 INSULIN RESISTANCE 4 0.0019
161 LIVEDO RETICULARIS 4 0.0019
162 HYPOMANIA 7 0.0019
163 SLEEP DEFICIT 4 0.0019
164 EYE CONTUSION 4 0.0019
165 FOETAL DISTRESS SYNDROME 4 0.0019
166 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 32 0.0019
167 INCORRECT DISPOSAL OF PRODUCT 6 0.0018
168 HORMONE LEVEL ABNORMAL 9 0.0018
169 GASTRIC BYPASS 4 0.0018
170 SEASONAL ALLERGY 26 0.0018
171 THERAPEUTIC RESPONSE UNEXPECTED 81 0.0018
172 TONGUE BLISTERING 4 0.0018
173 INFUSION SITE PAIN 23 0.0018
174 PHOTOPHOBIA 33 0.0018
175 EAR DISORDER 8 0.0017
176 SPEECH DISORDER DEVELOPMENTAL 5 0.0017
177 ORAL PRURITUS 4 0.0017
178 INFUSION SITE INFECTION 4 0.0017
179 PRODUCT COMMUNICATION ISSUE 15 0.0017
180 SINUS OPERATION 4 0.0017
181 MULTIPLE ALLERGIES 13 0.0017
182 INTENTIONAL DOSE OMISSION 47 0.0016
183 SLOW SPEECH 4 0.0016
184 POOR VENOUS ACCESS 17 0.0016
185 BODY TEMPERATURE ABNORMAL 3 0.0016
186 MATERNAL EXPOSURE TIMING UNSPECIFIED 6 0.0016
187 PREMATURE LABOUR 9 0.0016
188 INFUSION SITE SWELLING 10 0.0016
189 DYSPEPSIA 156 0.0016
190 PARANASAL SINUS DISCOMFORT 6 0.0016
191 PRODUCT PACKAGING ISSUE 15 0.0016
192 SINUS DISORDER 31 0.0016
193 LACTOSE INTOLERANCE 4 0.0016
194 VERTIGO 95 0.0016
195 VASCULAR DEVICE INFECTION 7 0.0015
196 VULVOVAGINAL MYCOTIC INFECTION 6 0.0015
197 NAUSEA 1207 0.0015
198 SINUS HEADACHE 9 0.0015
199 FEELING OF DESPAIR 7 0.0015
200 BLOOD POTASSIUM ABNORMAL 4 0.0015
201 PREMATURE BABY 45 0.0015
202 SENSITIVE SKIN 11 0.0015
203 DERMATITIS CONTACT 17 0.0015
204 BRUXISM 8 0.0015
205 SKIN DISCOMFORT 4 0.0015
206 MATERNAL EXPOSURE DURING BREAST FEEDING 6 0.0015
207 CLUMSINESS 4 0.0015
208 PAROSMIA 11 0.0015
209 TEMPERATURE INTOLERANCE 15 0.0015
210 MIDDLE INSOMNIA 27 0.0014
211 OROPHARYNGEAL DISCOMFORT 13 0.0014
212 SWELLING OF EYELID 9 0.0014
213 SOMNOLENCE 287 0.0014
214 FOOD ALLERGY 11 0.0014
215 EAR SWELLING 3 0.0014
216 TINNITUS 65 0.0014
217 OXYGEN SATURATION ABNORMAL 4 0.0014
218 IMPAIRED QUALITY OF LIFE 20 0.0014
219 HORDEOLUM 6 0.0014
220 HYPERTONIC BLADDER 4 0.0014
221 GASTROENTERITIS VIRAL 25 0.0014
222 TONGUE DISORDER 10 0.0014
223 FOETAL EXPOSURE DURING PREGNANCY 112 0.0014
224 EYELID PTOSIS 14 0.0014
225 FEELING ABNORMAL 330 0.0014
226 SOMNAMBULISM 9 0.0014
227 PETIT MAL EPILEPSY 7 0.0014
228 AUTONOMIC NERVOUS SYSTEM IMBALANCE 4 0.0014
229 PRODUCT TEMPERATURE EXCURSION ISSUE 7 0.0014
230 THROAT IRRITATION 61 0.0014
231 FAECES PALE 3 0.0013
232 WEIGHT FLUCTUATION 14 0.0013
233 ATYPICAL PNEUMONIA 4 0.0013
234 UPPER-AIRWAY COUGH SYNDROME 11 0.0013
235 AUTOIMMUNE DISORDER 13 0.0013
236 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 64 0.0013
237 SENSITIVITY TO WEATHER CHANGE 7 0.0013
238 AUTOIMMUNE THYROIDITIS 5 0.0013
239 CRANIOCEREBRAL INJURY 4 0.0013
240 BRAIN OPERATION 3 0.0013
241 INFUSION SITE ERYTHEMA 11 0.0013
242 ORAL DISCOMFORT 18 0.0013
243 FACIAL PARALYSIS 11 0.0013
244 MATERNAL EXPOSURE DURING PREGNANCY 115 0.0013
245 PANIC ATTACK 47 0.0013
246 MUSCLE RUPTURE 5 0.0013
247 HYPERSENSITIVITY 238 0.0013
248 SWOLLEN TONGUE 40 0.0013
249 BLEPHAROSPASM 8 0.0013
250 SKIN ABRASION 6 0.0013
251 UNEVALUABLE EVENT 96 0.0013
252 HEADACHE 789 0.0013
253 SINUS CONGESTION 17 0.0013
254 HYPERPHAGIA 5 0.0013
255 OCULAR DISCOMFORT 14 0.0012
256 PANIC REACTION 9 0.0012
257 SKIN EROSION 4 0.0012
258 MYASTHENIA GRAVIS 10 0.0012
259 PERIORBITAL SWELLING 7 0.0012
260 MAJOR DEPRESSION 9 0.0012
261 ABDOMINAL PAIN UPPER 252 0.0012
262 HUNGER 17 0.0012
263 NECK PAIN 68 0.0012
264 IMPAIRED WORK ABILITY 26 0.0012
265 PHOTOSENSITIVITY REACTION 20 0.0012
266 COVID-19 212 0.0012
267 PHARYNGITIS STREPTOCOCCAL 13 0.0012
268 POTENTIATING DRUG INTERACTION 4 0.0012
269 GLUCOSE TOLERANCE IMPAIRED 7 0.0012
270 THROAT TIGHTNESS 32 0.0012
271 APPENDICITIS PERFORATED 3 0.0012
272 SHOULDER OPERATION 5 0.0012
273 INITIAL INSOMNIA 12 0.0012
274 ABNORMAL UTERINE BLEEDING 3 0.0012
275 HEPATIC FIBROSIS 4 0.0012
276 ABNORMAL SENSATION IN EYE 5 0.0012
277 VARICOSE VEIN 6 0.0012
278 ABDOMINAL DISCOMFORT 194 0.0012
279 CATHETER SITE PAIN 3 0.0012
280 HAIR GROWTH ABNORMAL 8 0.0012
281 HYPOPNOEA 4 0.0012
282 UPPER RESPIRATORY TRACT INFECTION 53 0.0011
283 BEDRIDDEN 15 0.0011
284 FOOD CRAVING 6 0.0011
285 EAR INFECTION 30 0.0011
286 ANIMAL BITE 3 0.0011
287 INFUSION SITE EXTRAVASATION 7 0.0011
288 RHINITIS ALLERGIC 5 0.0011
289 HEREDITARY ANGIOEDEMA 12 0.0011
290 EYE PAIN 63 0.0011
291 NEPHROLITHIASIS 51 0.0011
292 MUSCLE TIGHTNESS 18 0.0011
293 BACK INJURY 12 0.0011
294 BLOOD THYROID STIMULATING HORMONE DECREASED 5 0.0011
295 HAEMOGLOBIN INCREASED 5 0.0011
296 FAECALOMA 6 0.0011
297 SURGERY 64 0.0011
298 PRODUCT ADMINISTRATION ERROR 22 0.0011
299 EYE OPERATION 5 0.0011
300 TASTE DISORDER 22 0.0011
301 CEREBRAL DISORDER 8 0.0011
302 ARTHROPOD BITE 8 0.0011
303 RETCHING 23 0.0011
304 HEART RATE ABNORMAL 6 0.0011
305 ROSACEA 5 0.0011
306 NOCTURIA 13 0.0011
307 ANAPHYLACTIC REACTION 59 0.0011
308 CHRONIC SINUSITIS 4 0.0011
309 INJECTION SITE URTICARIA 26 0.0011
310 SNORING 4 0.0011
311 FACE INJURY 4 0.0011
312 GASTROINTESTINAL DISORDER 94 0.0010
313 GASTRIC INFECTION 4 0.0010
314 EXERCISE TOLERANCE DECREASED 6 0.0010
315 MUSCLE TWITCHING 24 0.0010
316 DYSPNOEA AT REST 3 0.0010
317 FEEDING DISORDER 21 0.0010
318 PRODUCT DOSE OMISSION ISSUE 304 0.0010
319 APHTHOUS ULCER 8 0.0010
320 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 185 0.0010
321 PERIPHERAL COLDNESS 14 0.0010
322 FOOT OPERATION 5 0.0010
323 PRODUCT PRESCRIBING ERROR 24 0.0010
324 SMALL FOR DATES BABY 5 0.0010
325 GASTROOESOPHAGEAL REFLUX DISEASE 81 0.0010
326 SYMPTOM RECURRENCE 6 0.0010
327 GASTROINTESTINAL PAIN 11 0.0010
328 VEIN DISORDER 5 0.0010
329 FEELING JITTERY 19 0.0010
330 CEREBROVASCULAR DISORDER 3 0.0010
331 DRUG TOLERANCE 5 0.0010
332 VITAMIN B12 DEFICIENCY 4 0.0010
333 SLUGGISHNESS 10 0.0010
334 INCREASED TENDENCY TO BRUISE 9 0.0010
335 DEMYELINATION 4 0.0010
336 POOR QUALITY SLEEP 21 0.0010
337 HICCUPS 8 0.0010
338 PALPITATIONS 114 0.0010
339 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 6 0.0010
340 DEVICE DIFFICULT TO USE 64 0.0010
341 COLD SWEAT 17 0.0010
342 CONSTIPATION 209 0.0010
343 SENSATION OF FOREIGN BODY 8 0.0009
344 BLADDER PAIN 3 0.0009
345 MUSCLE FATIGUE 4 0.0009
346 FOREIGN BODY SENSATION IN EYES 6 0.0009
347 INTERVERTEBRAL DISC DISORDER 4 0.0009
348 FOOD POISONING 5 0.0009
349 DIZZINESS 464 0.0009
350 EAR PAIN 18 0.0009
351 HYSTERECTOMY 8 0.0009
352 ANTINUCLEAR ANTIBODY POSITIVE 3 0.0009
353 PARAESTHESIA 145 0.0009
354 SKIN LACERATION 10 0.0009
355 CHEST DISCOMFORT 94 0.0009
356 PRODUCT PREPARATION ISSUE 6 0.0009
357 HYPERSOMNIA 26 0.0009
358 NEURALGIA 22 0.0009
359 STREPTOCOCCAL INFECTION 5 0.0009
360 BRAIN INJURY 9 0.0009
361 NIGHTMARE 31 0.0009
362 SPINAL OPERATION 11 0.0009
363 SKIN INFECTION 10 0.0009
364 MENINGITIS ASEPTIC 4 0.0009
365 SLEEP APNOEA SYNDROME 17 0.0009
366 ADVERSE DRUG REACTION 80 0.0009
367 NASAL DISCOMFORT 7 0.0009
368 IMPAIRED DRIVING ABILITY 10 0.0009
369 SINUSITIS 90 0.0009
370 HEART RATE INCREASED 87 0.0009
371 SWELLING FACE 57 0.0009
372 RESPIRATION ABNORMAL 6 0.0009
373 DISCOMFORT 53 0.0009
374 BLOOD PRESSURE DIASTOLIC INCREASED 4 0.0009
375 FRUSTRATION TOLERANCE DECREASED 7 0.0009
376 URTICARIA 145 0.0009
377 FEAR 23 0.0009
378 BLOOD PRESSURE ABNORMAL 17 0.0009
379 PRODUCT DOSE OMISSION IN ERROR 24 0.0008
380 ENERGY INCREASED 5 0.0008
381 HAEMORRHAGIC DIATHESIS 3 0.0008
382 VOMITING 396 0.0008
383 LIP SWELLING 28 0.0008
384 ENDOMETRIOSIS 4 0.0008
385 PRODUCT AVAILABILITY ISSUE 19 0.0008
386 LIMB OPERATION 4 0.0008
387 ABNORMAL DREAMS 23 0.0008
388 RASH PRURITIC 45 0.0008
389 ADVERSE REACTION 11 0.0008
390 HYPOAESTHESIA 124 0.0008
391 APHASIA 25 0.0008
392 ERUCTATION 16 0.0008
393 RESTLESS LEGS SYNDROME 15 0.0008
394 BLOOD PHOSPHORUS DECREASED 3 0.0008
395 FOOD INTOLERANCE 3 0.0008
396 ANXIETY 233 0.0008
397 KIDNEY INFECTION 16 0.0008
398 NERVE INJURY 9 0.0008
399 DIPLOPIA 21 0.0008
400 DISORIENTATION 32 0.0008
401 SNEEZING 18 0.0008
402 CATHETER SITE INFECTION 3 0.0008
403 PHOTOPSIA 5 0.0008
404 VULVOVAGINAL PRURITUS 4 0.0008
405 SUICIDAL IDEATION 72 0.0008
406 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 23 0.0008
407 COMMUNICATION DISORDER 3 0.0008
408 EUPHORIC MOOD 8 0.0008
409 ROTATOR CUFF SYNDROME 10 0.0008
410 EXPOSURE VIA SKIN CONTACT 20 0.0008
411 ORAL HERPES 15 0.0008
412 RESPIRATORY TRACT INFECTION 20 0.0008
413 DYSGEUSIA 57 0.0008
414 TENDON DISORDER 5 0.0008
415 NASAL CONGESTION 45 0.0008
416 EYE IRRITATION 44 0.0008
417 ACCIDENTAL UNDERDOSE 11 0.0008
418 AFFECTIVE DISORDER 6 0.0008
419 SEIZURE 88 0.0008
420 DYSGRAPHIA 5 0.0008
421 BLOOD PRESSURE INCREASED 116 0.0008
422 TOOTH INFECTION 10 0.0008
423 NERVE COMPRESSION 7 0.0008
424 PRODUCT FORMULATION ISSUE 5 0.0008
425 MUSCULOSKELETAL DISCOMFORT 13 0.0008
426 EYE SWELLING 28 0.0008
427 FUNGAL INFECTION 25 0.0007
428 OBSESSIVE-COMPULSIVE DISORDER 6 0.0007
429 FLANK PAIN 7 0.0007
430 POST-TRAUMATIC STRESS DISORDER 5 0.0007
431 FIBROMYALGIA 18 0.0007
432 PRESYNCOPE 18 0.0007
433 POSTOPERATIVE WOUND INFECTION 5 0.0007
434 DRY MOUTH 60 0.0007
435 POST PROCEDURAL INFECTION 6 0.0007
436 FEELING HOT 45 0.0007
437 TIC 4 0.0007
438 AUTISM SPECTRUM DISORDER 4 0.0007
439 CYSTIC FIBROSIS 4 0.0007
440 GASTRITIS 19 0.0007
441 APHONIA 10 0.0007
442 INTERMENSTRUAL BLEEDING 4 0.0007
443 DERMATITIS ALLERGIC 9 0.0007
444 DRUG DOSE OMISSION BY DEVICE 56 0.0007
445 THERAPY INTERRUPTED 51 0.0007
446 COELIAC DISEASE 7 0.0007
447 THERAPY CHANGE 7 0.0007
448 SLEEP DISORDER 50 0.0007
449 ASTHMA 80 0.0007
450 ESCHERICHIA URINARY TRACT INFECTION 3 0.0007
451 EATING DISORDER 15 0.0007
452 SYSTEMIC LUPUS ERYTHEMATOSUS 25 0.0007
453 OVARIAN CYST 7 0.0007
454 PRURITUS 269 0.0007
455 NEUROLOGICAL SYMPTOM 4 0.0007
456 IRRITABLE BOWEL SYNDROME 15 0.0007
457 HERPES VIRUS INFECTION 4 0.0007
458 HYPERTHYROIDISM 10 0.0007
459 PRODUCT DISPENSING ERROR 15 0.0007
460 SEDATION 18 0.0007
461 INCORRECT DOSE ADMINISTERED BY DEVICE 18 0.0007
462 BURNING SENSATION 48 0.0007
463 SPINAL PAIN 8 0.0007
464 FEELING OF BODY TEMPERATURE CHANGE 4 0.0007
465 ORAL DISORDER 5 0.0007
466 GINGIVAL SWELLING 3 0.0007
467 VISUAL IMPAIRMENT 84 0.0007
468 BRADYKINESIA 4 0.0007
469 PLEURISY 4 0.0007
470 ACCIDENT 8 0.0007
471 RASH 291 0.0007
472 DISTURBANCE IN ATTENTION 36 0.0007
473 HEAVY MENSTRUAL BLEEDING 6 0.0007
474 VISION BLURRED 91 0.0007
475 LIMB INJURY 18 0.0007
476 DISABILITY 13 0.0007
477 EXOSTOSIS 6 0.0007
478 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
479 CONCOMITANT DISEASE AGGRAVATED 4 0.0006
480 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 11 0.0006
481 INJECTION SITE PAIN 198 0.0006
482 DERMATITIS ATOPIC 34 0.0006
483 CYST 8 0.0006
484 THINKING ABNORMAL 12 0.0006
485 CARPAL TUNNEL SYNDROME 9 0.0006
486 GASTROINTESTINAL INFLAMMATION 5 0.0006
487 PAIN IN JAW 18 0.0006
488 SPINAL DISORDER 6 0.0006
489 DRUG SCREEN POSITIVE 5 0.0006
490 MUSCULOSKELETAL DISORDER 12 0.0006
491 SPEECH DISORDER 33 0.0006
492 GAIT INABILITY 21 0.0006
493 RASH ERYTHEMATOUS 30 0.0006
494 ALOPECIA 123 0.0006
495 MALNUTRITION 7 0.0006
496 ABORTION SPONTANEOUS 25 0.0006
497 PRESCRIBED OVERDOSE 12 0.0006
498 LOSS OF CONSCIOUSNESS 79 0.0006
499 INSOMNIA 164 0.0006
500 SKIN FISSURES 12 0.0006
501 NERVOUSNESS 32 0.0006
502 DYSPNOEA EXERTIONAL 23 0.0006
503 VITREOUS FLOATERS 6 0.0006
504 THERAPEUTIC RESPONSE DECREASED 37 0.0006
505 DIABETIC NEUROPATHY 3 0.0006
506 CRYING 22 0.0006
507 MENSTRUAL DISORDER 5 0.0006
508 CHEST PAIN 111 0.0006
509 URINARY TRACT INFECTION 102 0.0006
510 MEMORY IMPAIRMENT 82 0.0006
511 BREAST MASS 4 0.0006
512 FATIGUE 463 0.0006
513 OFF LABEL USE 520 0.0006
514 HEPATIC STEATOSIS 11 0.0006
515 HYPERTENSION 125 0.0006
516 PRODUCT LABEL ISSUE 4 0.0006
517 DRUG DELIVERY SYSTEM MALFUNCTION 3 0.0006
518 VITAMIN D DECREASED 5 0.0006
519 ABDOMINAL DISTENSION 61 0.0006
520 PRODUCT CONTAINER ISSUE 5 0.0006
521 DRY EYE 29 0.0006
522 PARANOIA 10 0.0006
523 MUSCLE STRAIN 5 0.0006
524 SWELLING 54 0.0006
525 THERAPY PARTIAL RESPONDER 9 0.0006
526 ADRENAL INSUFFICIENCY 7 0.0006
527 TENDERNESS 6 0.0006
528 HEART RATE IRREGULAR 13 0.0006
529 FORMICATION 4 0.0006
530 MUSCLE SPASMS 105 0.0006
531 FLUSHING 58 0.0006
532 SPINAL OSTEOARTHRITIS 5 0.0006
533 BRONCHITIS 42 0.0006
534 INJECTION SITE PRURITUS 38 0.0006
535 RESPIRATORY TRACT CONGESTION 9 0.0006
536 THERAPY CESSATION 29 0.0006
537 HAND FRACTURE 4 0.0006
538 SCIATICA 9 0.0006
539 ANORECTAL DISCOMFORT 3 0.0006
540 CHOKING 11 0.0006
541 THERMAL BURN 4 0.0006
542 HYPOTHYROIDISM 18 0.0006
543 INJECTION SITE HAEMORRHAGE 45 0.0006
544 TRANSIENT ISCHAEMIC ATTACK 19 0.0006
545 LACRIMATION INCREASED 17 0.0006
546 INCORRECT DOSE ADMINISTERED 128 0.0006
547 FEAR OF INJECTION 4 0.0006
548 FACIAL PAIN 5 0.0006
549 HOT FLUSH 42 0.0006
550 VISUAL FIELD DEFECT 4 0.0006
551 FAECES SOFT 4 0.0005
552 APATHY 8 0.0005
553 DYSSTASIA 16 0.0005
554 INTENTIONAL PRODUCT USE ISSUE 48 0.0005
555 OCULAR HYPERAEMIA 26 0.0005
556 MANIA 9 0.0005
557 BRAIN NEOPLASM 5 0.0005
558 SKIN DISCOLOURATION 25 0.0005
559 INFUSION RELATED REACTION 36 0.0005
560 BLINDNESS TRANSIENT 4 0.0005
561 PSYCHOMOTOR HYPERACTIVITY 9 0.0005
562 OROPHARYNGEAL PAIN 50 0.0005
563 DYSPHAGIA 51 0.0005
564 HEAD INJURY 17 0.0005
565 APPENDICITIS 5 0.0005
566 THERAPY NON-RESPONDER 24 0.0005
567 DYSARTHRIA 20 0.0005
568 REBOUND EFFECT 6 0.0005
569 DEPRESSED MOOD 28 0.0005
570 INJECTION SITE BRUISING 42 0.0005
571 RHINORRHOEA 34 0.0005
572 INTENTIONAL PRODUCT MISUSE 46 0.0005
573 CHOLECYSTECTOMY 6 0.0005
574 EYE HAEMORRHAGE 7 0.0005
575 AMNESIA 34 0.0005
576 QUALITY OF LIFE DECREASED 7 0.0005
577 LETHARGY 30 0.0005
578 LOWER LIMB FRACTURE 10 0.0005
579 DYSKINESIA 21 0.0005
580 TREMOR 85 0.0005
581 DEPRESSION 116 0.0005
582 BALANCE DISORDER 44 0.0005
583 DECREASED INTEREST 3 0.0005
584 INJECTION SITE REACTION 35 0.0005
585 PAIN 312 0.0005
586 UNDERDOSE 37 0.0005
587 BLOOD IRON DECREASED 6 0.0005
588 DIVERTICULITIS 14 0.0005
589 BLADDER DISORDER 5 0.0005
590 INABILITY TO AFFORD MEDICATION 5 0.0005
591 INTERVERTEBRAL DISC PROTRUSION 11 0.0005
592 SALIVARY HYPERSECRETION 5 0.0005
593 BLOOD DISORDER 4 0.0005
594 TOOTHACHE 9 0.0005
595 NIGHT SWEATS 16 0.0005
596 RHINITIS 4 0.0005
597 BURSITIS 6 0.0005
598 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 100 0.0005
599 COGNITIVE DISORDER 23 0.0005
600 DRY THROAT 5 0.0005
601 GLOSSODYNIA 11 0.0005
602 TOOTH ABSCESS 5 0.0005
603 BLINDNESS 20 0.0005
604 PARALYSIS 7 0.0005
605 POLYURIA 4 0.0005
606 SPINAL COMPRESSION FRACTURE 4 0.0005
607 DISEASE RECURRENCE 23 0.0005
608 ARTHRITIS 38 0.0005
609 INJECTION SITE SWELLING 37 0.0005
610 IRRITABILITY 29 0.0005
611 MULTIPLE SCLEROSIS 23 0.0005
612 VIRAL INFECTION 16 0.0005
613 NERVOUS SYSTEM DISORDER 15 0.0005
614 SECRETION DISCHARGE 6 0.0005
615 EYE PRURITUS 16 0.0005
616 INFLUENZA 53 0.0005
617 GASTRIC ULCER 9 0.0005
618 ANGER 16 0.0005
619 ABDOMINAL PAIN 110 0.0005
620 NASOPHARYNGITIS 87 0.0005
621 BREAST PAIN 5 0.0005
622 POST PROCEDURAL COMPLICATION 9 0.0005
623 SCAR 8 0.0005
624 MOVEMENT DISORDER 15 0.0005
625 FEELING COLD 13 0.0005
626 ADVERSE EVENT 43 0.0005
627 MUSCULAR WEAKNESS 53 0.0005
628 BLOOD POTASSIUM DECREASED 14 0.0005
629 RESTLESSNESS 17 0.0005
630 BLOOD MAGNESIUM DECREASED 4 0.0005
631 HIATUS HERNIA 6 0.0005
632 CARDIAC MURMUR 4 0.0005
633 TACHYCARDIA 41 0.0005
634 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
635 FLATULENCE 26 0.0005
636 HYPERHIDROSIS 59 0.0005
637 BLOOD CALCIUM INCREASED 4 0.0005
638 GROIN PAIN 4 0.0005
639 CORONAVIRUS INFECTION 3 0.0005
640 APPETITE DISORDER 3 0.0005
641 LIMB DISCOMFORT 14 0.0005
642 ANKLE FRACTURE 7 0.0005
643 TENDONITIS 7 0.0005
644 LYMPHADENOPATHY 16 0.0005
645 SKIN DISORDER 15 0.0004
646 JOINT RANGE OF MOTION DECREASED 6 0.0004
647 ORAL PAIN 10 0.0004
648 MUSCULOSKELETAL STIFFNESS 39 0.0004
649 BLISTER 25 0.0004
650 ANAL INCONTINENCE 4 0.0004
651 GENERAL PHYSICAL CONDITION ABNORMAL 3 0.0004
652 PNEUMOTHORAX 7 0.0004
653 EPISTAXIS 33 0.0004
654 AGEUSIA 11 0.0004
655 OPTIC NEURITIS 4 0.0004
656 PREMATURE DELIVERY 7 0.0004
657 OBESITY 7 0.0004
658 HALLUCINATION 33 0.0004
659 WEIGHT INCREASED 98 0.0004
660 ECCHYMOSIS 3 0.0004
661 ACCIDENTAL OVERDOSE 16 0.0004
662 GASTRIC DISORDER 15 0.0004
663 DYSURIA 16 0.0004
664 IRON DEFICIENCY ANAEMIA 4 0.0004
665 BACK DISORDER 7 0.0004
666 ROAD TRAFFIC ACCIDENT 18 0.0004
667 DERMATITIS 9 0.0004
668 MASS 6 0.0004
669 ANAPHYLACTIC SHOCK 11 0.0004
670 MALAISE 187 0.0004
671 HALLUCINATION, VISUAL 9 0.0004
672 HEPATIC ENZYME INCREASED 29 0.0004
673 BLINDNESS UNILATERAL 6 0.0004
674 ARTERIOSCLEROSIS 4 0.0004
675 COVID-19 PNEUMONIA 5 0.0004
676 DRUG INTERACTION 67 0.0004
677 FOOT FRACTURE 8 0.0004
678 BACK PAIN 98 0.0004
679 CONDITION AGGRAVATED 127 0.0004
680 AFFECT LABILITY 4 0.0004
681 INCORRECT PRODUCT ADMINISTRATION DURATION 9 0.0004
682 DYSPNOEA 235 0.0004
683 INFLUENZA LIKE ILLNESS 34 0.0004
684 MENTAL IMPAIRMENT 10 0.0004
685 ENCEPHALOPATHY 10 0.0004
686 INFLAMMATION 21 0.0004
687 KNEE OPERATION 4 0.0004
688 INJECTION SITE MASS 15 0.0004
689 TENDON RUPTURE 5 0.0004
690 SKIN HAEMORRHAGE 6 0.0004
691 PALLOR 11 0.0004
692 TOOTH EXTRACTION 5 0.0004
693 RASH PAPULAR 9 0.0004
694 WEIGHT DECREASED 112 0.0004
695 SKIN LESION 11 0.0004
696 HEART RATE DECREASED 14 0.0004
697 BRAIN OEDEMA 5 0.0004
698 CEREBROVASCULAR ACCIDENT 67 0.0004
699 EXTRA DOSE ADMINISTERED 16 0.0004
700 ISCHAEMIC STROKE 7 0.0004
701 DISSOCIATION 3 0.0004
702 ARTHRALGIA 162 0.0004
703 URINARY RETENTION 13 0.0004
704 THYROID DISORDER 6 0.0004
705 EMOTIONAL DISORDER 12 0.0004
706 HAEMOLYSIS 3 0.0004
707 MUSCULOSKELETAL CHEST PAIN 6 0.0004
708 EYE DISCHARGE 4 0.0004
709 CHILLS 45 0.0004
710 PRODUCT USE IN UNAPPROVED INDICATION 95 0.0004
711 PRODUCT USE ISSUE 72 0.0004
712 ARTERIAL OCCLUSIVE DISEASE 3 0.0004
713 SARS-COV-2 TEST POSITIVE 5 0.0004
714 ACCIDENTAL EXPOSURE TO PRODUCT 39 0.0004
715 INCONTINENCE 4 0.0004
716 HALLUCINATION, AUDITORY 6 0.0004
717 HOSPITALISATION 58 0.0004
718 CONJUNCTIVITIS 7 0.0004
719 DYSMENORRHOEA 5 0.0004
720 CYSTITIS 12 0.0004
721 MOOD SWINGS 12 0.0004
722 JOINT INJURY 8 0.0004
723 SENSORY DISTURBANCE 6 0.0004
724 INJECTION SITE ERYTHEMA 46 0.0004
725 VAGINAL HAEMORRHAGE 16 0.0004
726 PRODUCT PRESCRIBING ISSUE 8 0.0004
727 PRODUCT STORAGE ERROR 32 0.0004
728 EYE DISORDER 12 0.0004
729 MYALGIA 62 0.0004
730 ECZEMA 19 0.0004
731 TOOTH FRACTURE 4 0.0004
732 GENERALISED TONIC-CLONIC SEIZURE 6 0.0004
733 DIARRHOEA 234 0.0004
734 DENTAL CARIES 4 0.0004
735 HEMIPLEGIA 3 0.0004
736 EOSINOPHIL COUNT INCREASED 3 0.0004
737 DYSPHONIA 21 0.0004
738 BONE PAIN 21 0.0004
739 PRODUCTIVE COUGH 17 0.0004
740 CANDIDA INFECTION 6 0.0004
741 ERYTHEMA 73 0.0004
742 WHEEZING 21 0.0004
743 FLUID RETENTION 18 0.0004
744 FALL 117 0.0004
745 SCAB 4 0.0004
746 BRONCHOSPASM 5 0.0004
747 MULTIPLE SCLEROSIS RELAPSE 24 0.0003
748 SYNCOPE 35 0.0003
749 NEOPLASM 4 0.0003
750 PSORIATIC ARTHROPATHY 14 0.0003
751 HYPOKINESIA 5 0.0003
752 RHEUMATOID ARTHRITIS 39 0.0003
753 JOINT STIFFNESS 9 0.0003
754 GRIP STRENGTH DECREASED 3 0.0003
755 INFECTION 49 0.0003
756 LIVER DISORDER 15 0.0003
757 THIRST 6 0.0003
758 CHOLECYSTITIS 4 0.0003
759 PULMONARY MASS 5 0.0003
760 GASTROINTESTINAL INFECTION 3 0.0003
761 MUSCLE RIGIDITY 4 0.0003
762 RESPIRATORY DISORDER 10 0.0003
763 STAPHYLOCOCCAL INFECTION 11 0.0003
764 WITHDRAWAL SYNDROME 14 0.0003
765 CONTUSION 32 0.0003
766 MOUTH ULCERATION 7 0.0003
767 COUGH 93 0.0003
768 EXPIRED PRODUCT ADMINISTERED 11 0.0003
769 DRY SKIN 44 0.0003
770 HIDRADENITIS 3 0.0003
771 AGITATION 24 0.0003
772 LIVER FUNCTION TEST INCREASED 7 0.0003
773 MUSCLE SPASTICITY 4 0.0003
774 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
775 PERIPHERAL SWELLING 50 0.0003
776 PROCEDURAL PAIN 9 0.0003
777 PAIN IN EXTREMITY 95 0.0003
778 ILEUS 4 0.0003
779 DIARRHOEA HAEMORRHAGIC 3 0.0003
780 BASAL CELL CARCINOMA 5 0.0003
781 MENINGIOMA 5 0.0003
782 INJECTION SITE DISCOLOURATION 4 0.0003
783 BLOOD SODIUM DECREASED 6 0.0003
784 BLOOD PRESSURE DECREASED 21 0.0003
785 EYE INFLAMMATION 3 0.0003
786 DECREASED APPETITE 73 0.0003
787 ULCER 5 0.0003
788 INCREASED APPETITE 6 0.0003
789 ASTHENIA 118 0.0003
790 POLLAKIURIA 13 0.0003
791 UNRESPONSIVE TO STIMULI 8 0.0003
792 CARDIAC DISORDER 29 0.0003
793 DIZZINESS POSTURAL 3 0.0003
794 SKIN EXFOLIATION 26 0.0003
795 HAEMORRHOIDS 6 0.0003
796 DEHYDRATION 41 0.0003
797 NEUROPATHY PERIPHERAL 29 0.0003
798 BODY TEMPERATURE DECREASED 3 0.0003
799 URINARY INCONTINENCE 9 0.0003
800 ORAL CANDIDIASIS 4 0.0003
801 PULMONARY CONGESTION 4 0.0003
802 PRESCRIBED UNDERDOSE 6 0.0003
803 BLOOD CHOLESTEROL INCREASED 14 0.0003
804 DRUG INTOLERANCE 29 0.0003
805 MENTAL DISORDER 13 0.0003
806 THROMBOSIS 24 0.0003
807 GAIT DISTURBANCE 57 0.0003
808 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
809 HEMIPARESIS 5 0.0003
810 INJURY ASSOCIATED WITH DEVICE 6 0.0003
811 MOBILITY DECREASED 21 0.0003
812 INTESTINAL OBSTRUCTION 11 0.0003
813 INJECTION SITE WARMTH 6 0.0003
814 TREATMENT FAILURE 24 0.0003
815 CEREBRAL INFARCTION 7 0.0003
816 RASH MACULAR 10 0.0003
817 CATARACT 17 0.0003
818 OSTEOARTHRITIS 12 0.0003
819 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
820 SKIN CANCER 6 0.0003
821 ANOSMIA 4 0.0003
822 PRODUCT COMPLAINT 7 0.0003
823 BIPOLAR DISORDER 3 0.0003
824 NEEDLE ISSUE 8 0.0003
825 CHOLELITHIASIS 9 0.0003
826 HYPOPHAGIA 7 0.0003
827 IMMUNODEFICIENCY 4 0.0003
828 DEAFNESS 7 0.0003
829 OSTEOPOROSIS 11 0.0003
830 EYE INFECTION 3 0.0003
831 FRACTURE 5 0.0003
832 STOMATITIS 16 0.0003
833 OSTEOPENIA 4 0.0003
834 MENSTRUATION IRREGULAR 7 0.0003
835 HERPES ZOSTER 15 0.0003
836 GASTRIC HAEMORRHAGE 3 0.0003
837 SEROTONIN SYNDROME 5 0.0003
838 ELECTROLYTE IMBALANCE 3 0.0003
839 OEDEMA 14 0.0003
840 DYSTONIA 5 0.0003
841 CAESAREAN SECTION 3 0.0003
842 MOOD ALTERED 7 0.0003
843 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
844 INJURY 18 0.0003
845 OVERDOSE 55 0.0003
846 CONFUSIONAL STATE 41 0.0003
847 ARRHYTHMIA 12 0.0003
848 CHRONIC KIDNEY DISEASE 19 0.0002
849 BLOOD PRESSURE FLUCTUATION 6 0.0002
850 SPINAL FRACTURE 5 0.0002
851 BLOOD POTASSIUM INCREASED 4 0.0002
852 PANCREATITIS 13 0.0002
853 BODY TEMPERATURE INCREASED 5 0.0002
854 PRODUCT SUBSTITUTION ISSUE 14 0.0002
855 RIB FRACTURE 5 0.0002
856 GENERALISED OEDEMA 3 0.0002
857 SKIN IRRITATION 11 0.0002
858 PERICARDITIS 4 0.0002
859 KNEE ARTHROPLASTY 5 0.0002
860 COLITIS 9 0.0002
861 SKIN BURNING SENSATION 17 0.0002
862 HAEMATEMESIS 6 0.0002
863 CARDIOVASCULAR DISORDER 6 0.0002
864 RENAL DISORDER 11 0.0002
865 SKIN ULCER 6 0.0002
866 JOINT SWELLING 28 0.0002
867 FAECES DISCOLOURED 5 0.0002
868 EPILEPSY 7 0.0002
869 INJECTION SITE RASH 7 0.0002
870 AMENORRHOEA 4 0.0002
871 ANKYLOSING SPONDYLITIS 3 0.0002
872 ABNORMAL BEHAVIOUR 9 0.0002
873 APPLICATION SITE PAIN 5 0.0002
874 TOOTH DISORDER 5 0.0002
875 GALLBLADDER DISORDER 4 0.0002
876 DIABETES MELLITUS 17 0.0002
877 PANCREATITIS ACUTE 5 0.0002
878 FREQUENT BOWEL MOVEMENTS 6 0.0002
879 CHROMATURIA 5 0.0002
880 LEUKOCYTOSIS 4 0.0002
881 TREATMENT NONCOMPLIANCE 12 0.0002
882 DEVICE DELIVERY SYSTEM ISSUE 6 0.0002
883 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
884 HIP FRACTURE 7 0.0002
885 PERICARDIAL EFFUSION 5 0.0002
886 DEVICE ISSUE 19 0.0002
887 NEOPLASM MALIGNANT 14 0.0002
888 RECTAL HAEMORRHAGE 9 0.0002
889 HYPOACUSIS 9 0.0002
890 LOCALISED INFECTION 5 0.0002
891 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
892 ATRIAL FIBRILLATION 20 0.0002
893 PNEUMONIA 66 0.0002
894 ANGIOEDEMA 9 0.0002
895 INTENTIONAL OVERDOSE 13 0.0002
896 PNEUMONIA ASPIRATION 5 0.0002
897 HAEMATOCHEZIA 11 0.0002
898 ARTHROPATHY 11 0.0002
899 ABDOMINAL PAIN LOWER 5 0.0002
900 ILL-DEFINED DISORDER 12 0.0002
901 CEREBRAL HAEMORRHAGE 7 0.0002
902 PRODUCT PREPARATION ERROR 4 0.0002
903 HAEMATOMA 5 0.0002
904 PYREXIA 66 0.0002
905 ABSCESS 3 0.0002
906 PAIN OF SKIN 5 0.0002
907 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
908 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
909 VISUAL ACUITY REDUCED 6 0.0002
910 DEMENTIA 5 0.0002
911 TYPE 2 DIABETES MELLITUS 6 0.0002
912 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
913 DEVICE DEFECTIVE 3 0.0002
914 ACNE 13 0.0002
915 DEVICE MALFUNCTION 12 0.0002
916 SEPSIS 19 0.0002
917 DEEP VEIN THROMBOSIS 11 0.0002
918 BLOOD GLUCOSE DECREASED 8 0.0002
919 BONE DISORDER 3 0.0002
920 LIVER INJURY 4 0.0002
921 BLOOD GLUCOSE ABNORMAL 3 0.0002
922 BACTERIAL INFECTION 3 0.0002
923 OXYGEN SATURATION DECREASED 9 0.0002
924 BLOOD URINE PRESENT 3 0.0002
925 COLITIS ULCERATIVE 7 0.0002
926 ACUTE RESPIRATORY FAILURE 3 0.0002
927 ERECTILE DYSFUNCTION 4 0.0002
928 HERNIA 3 0.0002
929 RENAL IMPAIRMENT 13 0.0002
930 COMPLICATION OF DEVICE INSERTION 3 0.0002
931 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 7 0.0001
932 HYPOTENSION 30 0.0001
933 HYPOGLYCAEMIA 7 0.0001
934 WOUND 4 0.0001
935 ANGINA PECTORIS 4 0.0001
936 CELLULITIS 7 0.0001
937 RESPIRATORY FAILURE 10 0.0001
938 LABORATORY TEST ABNORMAL 4 0.0001
939 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 7 0.0001
940 EMOTIONAL DISTRESS 16 0.0001
941 SUICIDE ATTEMPT 8 0.0001
942 BREAST CANCER 12 0.0001
943 BLOOD GLUCOSE INCREASED 24 0.0001
944 PULMONARY EMBOLISM 12 0.0001
945 COMA 6 0.0001
946 MEDICATION ERROR 7 0.0001
947 DEVICE BREAKAGE 5 0.0001
948 PLATELET COUNT DECREASED 13 0.0001
949 PRODUCT QUALITY ISSUE 16 0.0001
950 ANAEMIA 22 0.0001
951 DEVICE LEAKAGE 5 0.0001
952 DELIRIUM 4 0.0001
953 OEDEMA PERIPHERAL 14 0.0001
954 HAEMORRHAGE 12 0.0001
955 DEATH 97 0.0001
956 BREAST CANCER FEMALE 3 0.0001
957 ACUTE KIDNEY INJURY 17 0.0001
958 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
959 HYPERGLYCAEMIA 4 0.0001
960 BLOOD CREATININE INCREASED 7 0.0001
961 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
962 LUNG DISORDER 5 0.0001
963 ACUTE MYOCARDIAL INFARCTION 3 0.0001
964 WHITE BLOOD CELL COUNT DECREASED 11 0.0001
965 CARDIAC FAILURE CONGESTIVE 8 0.0001
966 NO ADVERSE EVENT 18 0.0001
967 CORONARY ARTERY DISEASE 3 0.0001
968 RENAL FAILURE 13 0.0001
969 MYOCARDIAL INFARCTION 17 0.0001
970 DRUG-INDUCED LIVER INJURY 3 0.0001
971 MUSCULOSKELETAL PAIN 5 0.0001
972 BRADYCARDIA 5 0.0001
973 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
974 DEVICE DISLOCATION 4 0.0001
975 PSORIASIS 12 0.0001
976 HAEMOGLOBIN DECREASED 9 0.0001
977 HAEMATURIA 3 0.0001
978 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
979 C-REACTIVE PROTEIN INCREASED 3 0.0001
980 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
981 AGGRESSION 4 0.0001
982 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
983 DRUG WITHDRAWAL SYNDROME 6 0.0001
984 CARDIAC FAILURE 5 0.0001
985 DRUG DEPENDENCE 8 0.0000
986 TOXICITY TO VARIOUS AGENTS 7 0.0000
987 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
988 DISEASE PROGRESSION 3 0.0000